Hepatitis A and HIV: a clinical review of disease and strategies for prevention. NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Hepatitis A and HIV: a clinical review of disease and strategies for prevention.

J Assoc Nurses AIDS Care. 1999 Mar-Apr;10(2):31-6. Unique Identifier : AIDSLINE MED/99164802
Kwong JJ; Fenway Community Health Center, Boston, USA.


Abstract: Hepatitis A, also known as infectious hepatitis, remains one of the more commonly transmitted types of viral hepatitis in the United States. Given the high prevalence of this illness, clinicians need to be aware not only about the clinical manifestations of this disease, but also about the special considerations that must be taken into account for persons coinfected with HIV. Antiretroviral management during acute hepatitis infection may be complicated by elevations of serum liver enzyme tests as well as by severe manifestations of associated symptoms such as nausea and vomiting. This article provides a brief overview of the clinical course of HIV infection and includes recommendations for antiretroviral medication management during acute illness. Additionally, strategies for prevention of disease are presented, with a focus on the efficacy and use of hepatitis A vaccines in persons with HIV.
Keywords: JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL Anti-HIV Agents/THERAPEUTIC USE Comorbidity Hepatitis/*COMPLICATIONS/DIAGNOSIS/NURSING/PREVENTION & CONTROL Human HIV Infections/*COMPLICATIONS/DRUG THERAPY Infection Control/METHODS Primary Prevention/METHODS VaccinationKWDjournalarticlereviewreview,tutorialanti-hivagents/therapeuticusecomorbidityhepatitis/KWDcomplications/diagnosis/nursing/prevention&controlhumanhivinfections/KWDcomplications/drugtherapyinfectioncontrol/methodsprimaryprevention/methodsvaccination
990730
A9971212

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .